Amneal Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.

CEO

Chintu Patel

CEOChintu Patel

Employees

8,300

Employees8,300

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

2002

Founded2002

Employees

8,300

Employees8,300

AMRX Key Statistics

Market cap

2.57B

Market cap2.57B

Price-Earnings ratio

1.18K

Price-Earnings ratio1.18K

Dividend yield

—

Dividend yield—

Average volume

1.53M

Average volume1.53M

High today

$8.21

High today$8.21

Low today

$8.01

Low today$8.01

Open price

$8.04

Open price$8.04

Volume

1.16M

Volume1.16M

52 Week high

$9.48

52 Week high$9.48

52 Week low

$6.69

52 Week low$6.69

AMRX News

Seeking Alpha 3d

Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate

Earnings Call Insights Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate Aug. 05, 2025 2:57 PM ET Amneal Pharmac...

Seeking Alpha 3d

Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M

Earnings News Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M Aug. 05, 2025 6:08 AM ET Amneal Pharmaceuticals, I...

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.